Exelon
NDC Package 21695-357-30
Package Information
Exelon is rivastigmine is used to treat confusion (dementia) related to Alzheimer's disease and to Parkinson's disease. Marketed by Rebel Distributors Corp, this product is identified by NDC 21695-357 and is authorized under FDA application NDA022083.
Identification & Billing
- RxCUI: 725021 - rivastigmine 4.6 MG/Day 24HR Transdermal System
- RxCUI: 725021 - 24 HR rivastigmine 0.192 MG/HR Transdermal System
- RxCUI: 725021 - rivastigmine 0.192 MG/HR 24 HR Transdermal Patch
- RxCUI: 725021 - rivastigmine 4.6 MG/Day 24 HR Transdermal Patch
- RxCUI: 751302 - EXELON PATCH 4.6 MG/DAY 24HR Transdermal System
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 21695 - Rebel Distributors Corp
- 21695-357 - Exelon
- 21695-357-30 - 30 PATCH in 1 CARTON / 24 [USP'U] in 1 PATCH
- 21695-357 - Exelon
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 21695-357-30 identifies a specific commercial package of 30 patch in 1 carton / 24 [usp'u] in 1 patch of Exelon, labeled by Rebel Distributors Corp. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rebel Distributors Corp on October 07, 2009. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
Rivastigmine is used to treat confusion (dementia) related to Alzheimer's disease and to Parkinson's disease. Rivastigmine does not cure either of these diseases, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by restoring the balance of natural substances (neurotransmitters) in the brain.
How is this Rebel Distributors Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 21695035730. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.